Contact this trialFirst, we need to learn more about you.
Rivaroxaban for Preventing Blood Clots in Sickle Cell Disease
Recruiting3 awardsPhase 3
London, Ontario
This trial will assess the safety & feasibility of using rivaroxaban to prevent blood clots in adults with sickle cell disease who have a central venous catheter.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.